ES2075934T3 - Metodo y composicion de iontoforesis. - Google Patents

Metodo y composicion de iontoforesis.

Info

Publication number
ES2075934T3
ES2075934T3 ES91302220T ES91302220T ES2075934T3 ES 2075934 T3 ES2075934 T3 ES 2075934T3 ES 91302220 T ES91302220 T ES 91302220T ES 91302220 T ES91302220 T ES 91302220T ES 2075934 T3 ES2075934 T3 ES 2075934T3
Authority
ES
Spain
Prior art keywords
supply
iontophoresis
composition
vasodilator
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91302220T
Other languages
English (en)
Inventor
Burton H Sage Jr
James E Riviere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/653,202 external-priority patent/US5302172A/en
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Application granted granted Critical
Publication of ES2075934T3 publication Critical patent/ES2075934T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Stringed Musical Instruments (AREA)
  • Paper (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of El Displays (AREA)

Abstract

LA INVENCION REVELA METODOS Y COMPOSICIONES PARA AUMENTAR EL SUMINISTRO IONTOFORETICO DE AGENTES ACTIVOS. LAS COMPOSICIONES SON FARMACEUTICAMENTE ACEPTABLES PARA EL SUMINISTRO IONTOFORETICO INCLUYENDO UN SUMINISTRO QUE AUMENTA LA CANTIDAD DE AGENTE VASODILATADOR Y ACTIVO. LOS METODOS INCLUYEN LA ADICION DE UN SUMINISTRO QUE AUMENTA LA CANTIDAD DE VASODILATADOR A UN AGENTE ACTIVO Y EL SUMINISTRO POR IONTOFORESIS.
ES91302220T 1990-03-15 1991-03-15 Metodo y composicion de iontoforesis. Expired - Lifetime ES2075934T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49406290A 1990-03-15 1990-03-15
US07/653,202 US5302172A (en) 1990-03-15 1991-02-08 Method and composition for iontophoresis

Publications (1)

Publication Number Publication Date
ES2075934T3 true ES2075934T3 (es) 1995-10-16

Family

ID=27051282

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91302220T Expired - Lifetime ES2075934T3 (es) 1990-03-15 1991-03-15 Metodo y composicion de iontoforesis.

Country Status (11)

Country Link
EP (1) EP0449463B1 (es)
JP (1) JPH074432B2 (es)
AT (1) ATE114466T1 (es)
AU (1) AU634867B2 (es)
DE (1) DE69105322T2 (es)
DK (1) DK0449463T3 (es)
ES (1) ES2075934T3 (es)
FI (1) FI911268A7 (es)
IE (1) IE64873B1 (es)
NO (1) NO911021L (es)
NZ (1) NZ237333A (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2863757B2 (ja) * 1992-02-17 1999-03-03 ドラッグ デリバリー システムズ インコーポレイテッド 電気的経皮薬剤アプリケータ
WO1994023748A1 (en) * 1993-04-08 1994-10-27 The University Of Queensland Administration of vaso-active agent and therapeutic agent
JP3916669B2 (ja) * 1996-06-12 2007-05-16 アルザ・コーポレーション 多塩基性アニオン対イオンを有する治療剤の強化電気的移送
US6004577A (en) * 1997-08-12 1999-12-21 Murdock; Thomas O. Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
US20060013866A1 (en) * 2004-07-16 2006-01-19 Carter Stephen G Transdermal drug delivery formulations with optimal amounts of vasodilators therein
US20060013769A1 (en) * 2004-07-16 2006-01-19 Stephen Carter Transdermal drug delivery formulations and method of determining optimal amounts of vasodilators therein
EP1968540A2 (en) * 2005-08-05 2008-09-17 Universite De Geneve Topical drug delivery by iontophoresis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659714A (en) * 1984-03-27 1987-04-21 Dentsply, Ltd. Anesthetic methods for mammals

Also Published As

Publication number Publication date
DK0449463T3 (da) 1995-01-23
EP0449463A3 (en) 1991-12-27
FI911268L (fi) 1991-09-16
IE64873B1 (en) 1995-09-20
JPH0679004A (ja) 1994-03-22
NO911021L (no) 1991-09-16
IE910715A1 (en) 1991-09-25
AU7278591A (en) 1991-09-19
EP0449463A2 (en) 1991-10-02
ATE114466T1 (de) 1994-12-15
NO911021D0 (no) 1991-03-14
DE69105322T2 (de) 1995-05-18
JPH074432B2 (ja) 1995-01-25
NZ237333A (en) 1993-08-26
EP0449463B1 (en) 1994-11-30
FI911268A0 (fi) 1991-03-14
AU634867B2 (en) 1993-03-04
DE69105322D1 (de) 1995-01-12
FI911268A7 (fi) 1991-09-16

Similar Documents

Publication Publication Date Title
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2177112T3 (es) Agentes angiostaticos y composiciones para tratar el glaucoma glc1a.
ES2161442T3 (es) Analogos de coralina como inhibidores de topoisomerasa.
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
ES2061507T3 (es) Derivados de piridinilpirimidina, metodo para su produccion, y un agente protector contra las enfermedades de las plantas que los contiene como ingrediente activo.
ES2107035T3 (es) Derivados de 3-azabiciclo(3.2.0)heptano n-substituidos como neurolepticos etc..
ES2123873T3 (es) Pirrolocarbazol.
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
ES2075934T3 (es) Metodo y composicion de iontoforesis.
ES2090083T3 (es) Derivados de cefalosporina, procedimiento para su preparacion y composicion antimicrobiana que contiene estos derivados.
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
BG30165A4 (en) Fungicide means and method for fungous fighting
AR005970A1 (es) Compuestos de benzotiofeno y formulaciones farmaceuticas que los contienen como agente activo
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.
AR025351A1 (es) Agonistas retinoides selectivos par
MX173194B (es) Composicion de tratamiento contra piojos
ES2057759T3 (es) Composicion de iontoforesis para aumentar la concentracion de agentes activos en la piel.
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.
PE58099A1 (es) Ureas y carbamatos enlazados en n de esteres heterociclicos
ES2059396T3 (es) Derivados de indeno y metodos.
JO998B1 (en) Benzo dioxide derivatives of new oxol, methods of preparation and uses as collaborating materials in formulations that eliminate insects and fascias
CO4230094A1 (es) Composiciones
ES2127758T3 (es) Nuevos inhibidores de la alfa-manosidasa.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 449463

Country of ref document: ES